FDA Updates on GLP-1 Medications - February 2026

Hey everyone! Sharing some important FDA updates on GLP-1 medications.

Current FDA-Approved GLP-1s

The FDA has approved several GLP-1 receptor agonists:

  • Semaglutide (Ozempic, Wegovy, Rybelsus)
  • Tirzepatide (Mounjaro, Zepbound)
  • Liraglutide (Victoza, Saxenda)

For official prescribing information, always check FDA Drug Database.

Compounding Situation

The FDA maintains a drug shortage list. When a drug is on this list, 503A and 503B pharmacies may compound alternatives.

Important: Only use compounded medications from licensed pharmacies!

Safety Reminders

  • Always consult with a healthcare provider
  • Report side effects to FDA MedWatch
  • Be cautious of “research chemical” sources

Questions? Drop them below!